Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Jun-23 4:05 PM View:  | Hoffman Robert President, CEO, and CFO Director | Del Mar Pharmaceuticals Inc. (HURA) | 01-Jun-23 | Grant | 59,800 | -- | -- | 657% 9.1K to 68.9K | |
| 06-Jan-23 7:26 PM View: | Brown Dennis M Chief Scientific Officer | Del Mar Pharmaceuticals Inc. (HURA) | 05-Jan-23 | txn.W.title | 363 | -- | -- | 6% 6.01K to 6.38K | |
| 03-Aug-22 4:30 PM View: | Praill Scott Chief Financial Officer | Del Mar Pharmaceuticals Inc. (HURA) | 01-Aug-22 | Grant | 240,087 | -- | -- | 646% 37.19K to 277.27K | |
| 03-Aug-22 4:30 PM View: | Brown Dennis M Chief Scientific Officer | Del Mar Pharmaceuticals Inc. (HURA) | 01-Aug-22 | Grant | 240,087 | -- | -- | 396% 60.57K to 300.65K | |
| 03-Aug-22 4:30 PM View: | Hoffman Robert President and CEO Director | Del Mar Pharmaceuticals Inc. (HURA) | 01-Aug-22 | Grant | 400,145 | -- | -- | 728% 55.0K to 455.14K | |
| 17-Feb-22 4:00 PM View: | Hoffman Robert President and CEO Director | Del Mar Pharmaceuticals Inc. (HURA) | 15-Feb-22 | Market Purchase | 55,000 | $0.47 | $25,795.00 | 100% 0 to 55.0K | 9% |
| 09-Dec-21 4:09 PM View: | Praill Scott Chief Financial Officer | Del Mar Pharmaceuticals Inc. (HURA) | 08-Dec-21 | Market Purchase | 28,700 | $0.68 | $19,429.90 | 338% 8.49K to 37.19K | 5% |
| 08-Dec-21 4:09 PM View: | Zarrabian Saiid Head of Strategic Partnerships Director | Del Mar Pharmaceuticals Inc. (HURA) | 07-Dec-21 | Market Purchase | 38,109 | $0.64 | $24,298.30 | 212% 17.98K to 56.09K | 2% |
| 08-Dec-21 4:09 PM View: | Zarrabian Saiid Head of Strategic Partnerships Director | Del Mar Pharmaceuticals Inc. (HURA) | 06-Dec-21 | Market Purchase | 11,891 | $0.59 | $7,018.07 | 195% 6.09K to 17.98K | 10% |
| 24-Nov-21 4:06 PM View: | Douglass Laura L. Director | Del Mar Pharmaceuticals Inc. (HURA) | 22-Nov-21 | Market Purchase | 3,000 | $0.74 | $2,226.90 | 100% 0 to 3.0K | (< 1%) |
| 29-Apr-21 4:05 PM View: | Toth Robert Joseph Jr Director | Del Mar Pharmaceuticals Inc. (HURA) | 29-Apr-21 | Conversion | 325 | -- | -- | 26% 1.24K to 1.56K | |
| 29-Apr-21 4:06 PM View: | Brown Dennis M Chief Scientific Officer | Del Mar Pharmaceuticals Inc. (HURA) | 29-Apr-21 | Conversion | 750 | -- | -- | 1% 59.81K to 60.56K | |
| 29-Apr-21 4:05 PM View: | Toth Robert Joseph Jr Director | Del Mar Pharmaceuticals Inc. (HURA) | 29-Apr-21 | Acquisition (other) | 3 | -- | -- | < 1% 1.56K to 1.57K | |
| 29-Apr-21 4:06 PM View: | Praill Scott Chief Financial Officer | Del Mar Pharmaceuticals Inc. (HURA) | 29-Apr-21 | Conversion | 938 | -- | -- | 12% 7.54K to 8.48K | |
| 29-Apr-21 4:06 PM View: | Brown Dennis M Chief Scientific Officer | Del Mar Pharmaceuticals Inc. (HURA) | 29-Apr-21 | Acquisition (other) | 6 | -- | -- | < 1% 60.56K to 60.57K | |
| 29-Apr-21 4:06 PM View: | Praill Scott Chief Financial Officer | Del Mar Pharmaceuticals Inc. (HURA) | 29-Apr-21 | Acquisition (other) | 8 | -- | -- | < 1% 8.48K to 8.49K | |
| 31-Mar-21 4:14 PM View: | Toth Robert Joseph Jr Director | Del Mar Pharmaceuticals Inc. (HURA) | 31-Mar-21 | Acquisition (other) | 8 | -- | -- | < 1% 1.23K to 1.24K | |
| 31-Mar-21 4:11 PM View: | Brown Dennis M Chief Scientific Officer | Del Mar Pharmaceuticals Inc. (HURA) | 31-Mar-21 | Acquisition (other) | 17 | -- | -- | < 1% 59.8K to 59.81K | |
| 31-Mar-21 4:08 PM View: | Praill Scott Chief Financial Officer | Del Mar Pharmaceuticals Inc. (HURA) | 31-Mar-21 | Acquisition (other) | 22 | -- | -- | < 1% 7.52K to 7.54K | |
| 04-Jan-21 8:01 AM View: | Brown Dennis M Chief Scientific Officer | Del Mar Pharmaceuticals Inc. (HURA) | 31-Dec-20 | Acquisition (other) | 17 | -- | -- | < 1% 59.78K to 59.8K | |
| 04-Jan-21 8:00 AM View: | Praill Scott Chief Financial Officer | Del Mar Pharmaceuticals Inc. (HURA) | 31-Dec-20 | Acquisition (other) | 22 | -- | -- | < 1% 7.5K to 7.52K | |
| 04-Jan-21 8:00 AM View: | Toth Robert Joseph Jr Director | Del Mar Pharmaceuticals Inc. (HURA) | 31-Dec-20 | Acquisition (other) | 8 | -- | -- | < 1% 1.22K to 1.23K | |
| 30-Sep-20 4:06 PM View: | Toth Robert Joseph Jr Director | Del Mar Pharmaceuticals Inc. (HURA) | 30-Sep-20 | Acquisition (other) | 8 | -- | -- | < 1% 1.21K to 1.22K | |
| 30-Sep-20 4:05 PM View: | Brown Dennis M Chief Scientific Officer | Del Mar Pharmaceuticals Inc. (HURA) | 30-Sep-20 | Acquisition (other) | 17 | -- | -- | < 1% 59.76K to 59.78K | |
| 30-Sep-20 4:06 PM View: | Praill Scott Chief Financial Officer | Del Mar Pharmaceuticals Inc. (HURA) | 30-Sep-20 | Acquisition (other) | 22 | -- | -- | < 1% 7.47K to 7.5K | |
| 21-Aug-20 4:16 PM View: | Murphy Keith Director | Del Mar Pharmaceuticals Inc. (HURA) | 19-Aug-20 | Purchase | 181,010 | -- | -- | 100% 0 to 181.01K | |
| 21-Aug-20 4:17 PM View: | Liatos John SVP, Business Development Director | Del Mar Pharmaceuticals Inc. (HURA) | 19-Aug-20 | Purchase | 196,750 | -- | -- | 100% 0 to 196.75K | |
| 30-Jun-20 4:14 PM View: | Bell John K Director | Del Mar Pharmaceuticals Inc. (HURA) | 30-Jun-20 | Acquisition (other) | 29 | -- | -- | < 1% 44.79K to 44.82K | |
| 30-Jun-20 4:16 PM View: | Cranston Lynda Sarah Director | Del Mar Pharmaceuticals Inc. (HURA) | 30-Jun-20 | Disposition (other) Duplicate | 8 | -- | -- | (2%) 0.34K to 0.33K | |
| 30-Jun-20 4:12 PM View: | Toth Robert Joseph Jr Director | Del Mar Pharmaceuticals Inc. (HURA) | 30-Jun-20 | Acquisition (other) | 8 | -- | -- | < 1% 1.21K to 1.21K | |
| 30-Jun-20 4:17 PM View: | Praill Scott Chief Financial Officer | Del Mar Pharmaceuticals Inc. (HURA) | 30-Jun-20 | Acquisition (other) | 22 | -- | -- | < 1% 7.45K to 7.47K | |
| 30-Jun-20 4:07 PM View: | Brown Dennis M Chief Scientific Officer | Del Mar Pharmaceuticals Inc. (HURA) | 30-Jun-20 | Acquisition (other) | 17 | -- | -- | < 1% 59.74K to 59.76K | |
| 31-Mar-20 4:28 PM View: | Praill Scott Chief Financial Officer | Del Mar Pharmaceuticals Inc. (HURA) | 31-Mar-20 | Acquisition (other) | 22 | -- | -- | < 1% 7.43K to 7.45K | |
| 31-Mar-20 4:15 PM View: | Brown Dennis M Chief Scientific Officer | Del Mar Pharmaceuticals Inc. (HURA) | 31-Mar-20 | Acquisition (other) | 17 | -- | -- | < 1% 59.73K to 59.74K | |
| 31-Mar-20 4:15 PM View: | Bell John K Director | Del Mar Pharmaceuticals Inc. (HURA) | 31-Mar-20 | Acquisition (other) | 29 | -- | -- | < 1% 44.76K to 44.79K | |
| 31-Mar-20 4:16 PM View: | Cranston Lynda Sarah Director | Del Mar Pharmaceuticals Inc. (HURA) | 31-Mar-20 | Disposition (other) Duplicate | 8 | -- | -- | (2%) 0.33K to 0.32K | |
| 31-Mar-20 4:18 PM View: | Toth Robert Joseph Jr Director | Del Mar Pharmaceuticals Inc. (HURA) | 31-Mar-20 | Acquisition (other) | 8 | -- | -- | < 1% 1.2K to 1.21K | |
| 02-Jan-20 4:20 PM View: | Brown Dennis M Chief Scientific Officer | Del Mar Pharmaceuticals Inc. (HURA) | 31-Dec-19 | Acquisition (other) | 17 | -- | -- | < 1% 59.71K to 59.73K | |
| 02-Jan-20 4:10 PM View: | Bell John K Director | Del Mar Pharmaceuticals Inc. (HURA) | 31-Dec-19 | Acquisition (other) | 29 | -- | -- | < 1% 44.73K to 44.76K | |
| 02-Jan-20 4:15 PM View: | Cranston Lynda Sarah Director | Del Mar Pharmaceuticals Inc. (HURA) | 31-Dec-19 | Acquisition (other) Duplicate | 8 | -- | -- | 3% 0.31K to 0.32K | |
| 02-Jan-20 4:12 PM View: | Toth Robert Joseph Jr Director | Del Mar Pharmaceuticals Inc. (HURA) | 31-Dec-19 | Acquisition (other) | 8 | -- | -- | < 1% 1.19K to 1.2K | |
| 02-Jan-20 4:17 PM View: | Praill Scott Chief Financial Officer | Del Mar Pharmaceuticals Inc. (HURA) | 31-Dec-19 | Acquisition (other) | 22 | -- | -- | < 1% 7.41K to 7.43K | |
| 02-Jan-20 4:20 PM View: | Brown Dennis M Chief Scientific Officer | Del Mar Pharmaceuticals Inc. (HURA) | 27-Dec-19 | Gift | 7,500 | -- | -- | (11%) 67.21K to 59.71K | |
| 01-Oct-19 4:20 PM View: | Bell John K Director | Del Mar Pharmaceuticals Inc. (HURA) | 30-Sep-19 | Acquisition (other) | 29 | -- | -- | < 1% 44.7K to 44.73K | |
| 01-Oct-19 4:22 PM View: | Cranston Lynda Sarah Director | Del Mar Pharmaceuticals Inc. (HURA) | 30-Sep-19 | Acquisition (other) Duplicate | 8 | -- | -- | 3% 0.3K to 0.31K | |
| 01-Oct-19 4:32 PM View: | Toth Robert Joseph Jr Director | Del Mar Pharmaceuticals Inc. (HURA) | 30-Sep-19 | Acquisition (other) | 8 | -- | -- | < 1% 1.18K to 1.19K | |
| 01-Oct-19 4:14 PM View: | Praill Scott Chief Financial Officer | Del Mar Pharmaceuticals Inc. (HURA) | 30-Sep-19 | Acquisition (other) | 22 | -- | -- | < 1% 7.39K to 7.41K | |
| 01-Oct-19 4:09 PM View: | Brown Dennis M Chief Scientific Officer | Del Mar Pharmaceuticals Inc. (HURA) | 30-Sep-19 | Acquisition (other) | 17 | -- | -- | < 1% 67.19K to 67.21K | |
| 16-Sep-19 4:22 PM View: | Bell John K Director | Del Mar Pharmaceuticals Inc. (HURA) | 13-Sep-19 | Market Purchase | 35,000 | $0.68 | $23,744.00 | 361% 9.7K to 44.7K | 140% |
| 01-Jul-19 4:21 PM View: | Praill Scott Chief Financial Officer | Del Mar Pharmaceuticals Inc. (HURA) | 28-Jun-19 | Acquisition (other) | 22 | -- | -- | < 1% 7.36K to 7.39K |
